EL
Enliven
ELVN·NASDAQBoulder COFounded 202050 employees
Small CapbiotechPublicOncology
Platform: Switch Kinase
Market Cap
$1B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ELVN)
Loading ELVN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ELV-1411 | ELV-1411 | NDA/BLA | 2 | HER2 | MCCSLE | ||
| Tezesotorasib | ELV-9243 | Phase 2 | 2 | USP1 | Atopic DermHS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)